Outsourced Pharma

🤝 CMC Compliance Through CDMO Collaborations Join our virtual event on May 14th to explore the critical role CDMOs play in achieving and maintaining CMC compliance across the drug development lifecycle. Participants will gain practical insights on aligning CMC compliance strategies with CDMO capabilities for successful drug launches. 🔐 Secure your spot today: https://lnkd.in/enzTxgP6 🗣️ Speakers: Jumai Abioye, PhD, Founder & CEO, PanAccess Innovations Inc. Sai Prathyusha Bhamidipati-MS, RAC-US, LSS-GB, Director, Reg CMC, Moderna Dileep Boinipally, Director, Drug Product Formulation, Metsera Bikash Chatterjee, President & Chief Science Officer, Pharmatech Associates, a USP company Louis Garguilo, Chief Editor, Outsourced Pharma Sponsored by Curia

REPORT: View the latest Contract Manufacturing: Opportunities and Threats summary to identify CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections: https://lnkd.in/eswc24Mf Each month, Outsourced Pharma works in conjunction with PharmSource, part of Global Data Plc, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers.

Searching for a CDMO with expertise in Fill/Finish processes? Join the Outsourced Pharma Fill/Finish Capacity Update TOMORROW (4/25), where CDMOs will introduce you to the latest sterile filling, lyophilization, and advanced packaging technologies. Register here for the digital event: https://lnkd.in/eJhTF3MN

Looking for a partner in Cell & Gene Therapy with available capacity? The Outsourced Pharma Cell & Gene Therapy Capacity Update happening TOMORROW (4/24) will showcase CDMO presentations that venture into the fast-developing areas of cell and gene therapy, covering a wide range of services from cell sourcing and expansion to vector design for gene therapy. Reserve your spot here for the virtual event: https://lnkd.in/e3q_9JZ6

3D Screen Printing: Breakthrough Solutions for Patient-Centric Therapies Virtual Event | April 29, 2025 Join us and our experts to explore the breakthrough potential of 3D screen printing in pharmaceutical manufacturing, a technology that overcomes the scalability and formulation challenges of earlier 3D printing methods. Learn how this cutting-edge technology streamlines drug development, enhances manufacturing efficiency, and paves the way for the next generation of personalized medicine. Reserve your spot: https://lnkd.in/ePVBswVi 🎙️ Expert Speakers: - Klaus Kühne, Chief Operations Officer, Laxxon Medical - Steven Facer, Senior Vice President of Global Sales and Marketing, Adare Pharma Solutions #3dscreenprinting #3Dpharmaceuticalprinting #drugdevelopment #pharmaceuticalmanufacturing

Does a perfect CDMO match exist for your small molecule project? Join us TOMORROW (4/23) at the Outsourced Pharma Small Molecule Capacity Update to watch top CDMOs present their available capacity and capabilities to help you select the best options for your small molecule project's requirements!   Register for the virtual event here: https://lnkd.in/ewbUiyaB Sponsored by Pharma Expanse

Don't miss our NEW Analytical Services Capacity Update on April 22nd! It's a great opportunity to get an inside look at the available capacity and capabilities of industry suppliers. Register for the virtual event: https://lnkd.in/eAqkytje

In this week's issue we'll explore: ◾ Why Your CDMO BD Contact Matters More Than You Think ◾ The Costs Of Disengagement From China ◾ Oral Therapies Take Center Stage For PsO And PsA Treatment ◾ Your Most Pressing Tech Transfer Questions Answered ◾ EMA Issues Paper On Qualifying Non-Mutagenic Impurities For Drug Toxicological Safety and More! Louis Garguilo, Outsourced Pharma | Vincent Kosewski, KALA BIO | Robert Discordia, PhD, EQUULUS Therapeutics | Jack Gordon, Adam Pow, Lifescience Dynamics Limited | Edyta Bartusik-Czubek, Izabela Kuskowska, Marta Bednarek, Mabion S.A. | Professor Tim Sandle, Ph.D., CBiol, FIScT | Karim Abdelkader, INCOG BioPharma Services | GlobalData Plc | Dave A. Miller, Ph.D., AustinPx | Ajaz H. | Labcorp

Which CDMO is the best fit for your large molecule project? Join our Large Molecule Capacity Update TOMORROW (4/22) to watch leading CDMOs share their current available capacity and capabilities to help with your project's needs!   Register for the virtual event: https://lnkd.in/eK4B24CK  

Searching for a CDMO with Expertise in Antibody-Drug Conjugates? Our ADC Capacity Update taking place TOMORROW (4/21) is a great opportunity to get an inside look at the available capacity and capabilities of industry suppliers! Register here for the virtual event: https://lnkd.in/e9Hq3H_g